tiprankstipranks
Galectin Therapeutics (GALT) (GALT)
NASDAQ:GALT
US Market
GALT
Galectin Therapeutics
RESEARCH TOOLSreports
Want to see GALT full AI Analyst Report?

Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?

672 Followers

Galectin Therapeutics (GALT) Ownership Overview

26.04%3.82%4.52%3.20%62.42%
26.04% Insiders
3.82% Mutual Funds
4.52% Other Institutional Investors
3.20% ETFs
62.42% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 11.54% of the company’s stock is owned by Institutional Investors, 26.04% is owned by Insiders, and 62.42% is owned by Public Companies and Individual Investors.
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 8.34% of the company’s stock is owned by Institutional Investors, 26.04% is owned by Insiders, and 3.20% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 09, 2026
Kary Eldred
xxxxxxxxxxxxx
$810
Jan 13, 2026
Joel Lewis
xxxxxxxxxxxxx
$218568
Dec 23, 2025
Kevin D. Freeman
xxxxxxxxxxxxx
$19470
Dec 23, 2025
Kary Eldred
xxxxxxxxxxxxx
$2611
Show More Insider Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,360,386Insider15.73%32,324,404
5,614,457Insider8.53%17,517,106
1,946,148Institution2.96%6,071,982
1,915,073Institution2.91%5,975,028
778,260Insider1.18%2,428,171
491,640Institution0.75%1,533,917
137,269Insider0.21%428,279
114,442Institution0.17%357,059
70,107Insider0.11%218,734
66,769Insider0.10%208,319

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,915,073Institution2.91%5,975,028
491,640Institution0.75%1,533,917
29,970Institution0.05%93,506
26,902Institution0.04%83,934
24,567Institution0.04%76,649
22,865Institution0.03%71,339
4,772Institution<0.01%14,889
1,086Institution<0.01%3,388
289Institution<0.01%902
232Institution<0.01%724

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
Vanguard Total Stock Market ETF
1,351,443Institution2.05%3,405,636
Vanguard Extended Market ETF
594,705Institution0.90%1,498,657
iShares Micro-Cap ETF
114,442Institution0.17%357,059
Horizon Kinetics Medical ETF
46,968Institution0.07%131,510

FAQ

Who Owns Galectin Therapeutics (GALT) (GALT)?
According to the latest TipRanks data, approximately 4.52% of the company's stock is held by institutional investors, 26.04% is held by insiders, and 62.42% is held by retail investors.
    What percentage of Galectin Therapeutics (GALT) (GALT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 4.52% of Galectin Therapeutics (GALT) (GALT) stock is held by institutional investors.
      What percentage of Galectin Therapeutics (GALT) (GALT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 62.42% of Galectin Therapeutics (GALT) (GALT) stock is held by retail investors.
        Who owns the most shares of Galectin Therapeutics (GALT) (GALT)?
        Richard E Uihlein owns the most shares of Galectin Therapeutics (GALT) (GALT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.